Ward et al., 1964 - Google Patents
The parathyroids, calcium and gastric secretion in man and the dogWard et al., 1964
View PDF- Document ID
- 7219460830747693050
- Author
- Ward J
- Adesola A
- Welbourn R
- Publication year
- Publication venue
- Gut
External Links
Snippet
SUMMARY OF MAIN EXPERIMENTAL OBSERVATIONS ON INFLUENCE OF PARATHYROID GLANDS AND CALCIUM ON GASTRIC SECRETION IN NORMAL HUMAN SUBJECTS AND IN ANIMALS (FINDINGS IN HYPER-AND HYPOPARATHYROIDISM IN …
- 230000028327 secretion 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/866—Diabetes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ward et al. | The parathyroids, calcium and gastric secretion in man and the dog | |
Melvin et al. | The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. | |
Harris et al. | Pyridoxine responsive anemia in the human adult. | |
Mogensen | Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects | |
GREGERMAN et al. | Estimation of thyroxine secretion rate in the rat by the radioactive thyroxine turnover technique: influences of age, sex and exposure to cold | |
Odell et al. | Studies of thyrotropin physiology by means of radioimmunoassay. | |
Gross et al. | 3: 5: 3′-Triiodothyronine. 2. Physiological activity | |
Jepson et al. | The effects of endotoxaemia on protein metabolism in skeletal muscle and liver of fed and fasted rats | |
WEEKE et al. | Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men | |
Moorhead et al. | Hypophosphataemic osteomalacia after cadaveric renal transplantation | |
Sanderson et al. | Calcium and phosphorus homeostasis in the parathyroidectomized dog; evaluation by means of ethylenediamine tetraacetate and calcium tolerance tests | |
Carter et al. | Inhibition of conversion of thyroxine to triiodothyronine in patients with severe chronic illness | |
Goldberg et al. | The mechanism of depression of plasma protein bound iodine by 2, 4 dinitrophenol | |
Schiffrin | Relationship between the parathyroid and the gastric glands in the dog | |
Konturek et al. | Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer. | |
Williams et al. | Further studies of the absorption, distribution, and elimination of thiouracil | |
KOKKA et al. | Immunoassay of plasma growth hormone in cats following fasting and administration of insulin, arginine, 2-deoxyglucose and hypothalamic extract | |
Rosenberg et al. | Thyrotropin-induced release of iodide from the thyroid | |
Karp et al. | Thyrotoxicosis from molar thyrotropin | |
Berkowitz et al. | Factitious hypoglycemia: Why not diagnose before laparotomy? | |
TALMAGE et al. | CHANGES IN EXTRACELLULAR FLUID LEVELS OFCALCIUM, PHOSPHATE AND CITRATE IONS IN NEPHRECTOMIZED RATS FOLLOWING PARATHYROIDECTOMY | |
Oakley | Effect of" fractionated" insulins on total plasma insulin binding capacity and insulin requirement in severe diabetes | |
Albert et al. | The behavior of labeled thyroglobulin and labeled thyroxine in patients with myxedema | |
MORSE | CORRELATION OF INSULIN REQUIREMENTS WITH THE CONCENTRATION OF INSULINBINDING ANTIBODY IN TWO CASES OF INSULIN RESISTANCE | |
Behrmann et al. | Blood histamine levels in experimental burns |